Recent Updates
Recently added Catalysts
RIGL Positive Sentiment Score: 70/100

Rigel to Present at the Jefferies 2023 Global Healthcare Conference

Wednesday, May 31, 2023 1 min read
Key Takeaway: Rigel Pharmaceuticals, Inc. announced that CEO Raul Rodriguez will present at the Jefferies 2023 Global Healthcare Conference on June 7, 2023. The event will be held in New York and aims to provide insights into Rigel's advancements in therapies for hematologic disorders and cancer. Investors and interested parties will be able to access the live webcast through the company's website. This presentation underscores Rigel's focus on novel therapies and enhancing patient care.

Market Sentiment Analysis

POSITIVE FACTORS

  • Rigel Pharmaceuticals to showcase developments at a significant healthcare conference.
  • Presentation highlights commitment to improving therapies for hematologic disorders and cancer.
  • Opportunity for investor engagement and visibility in the biotech industry.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., May 31, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, will present on Wednesday, June 7, 2023 at 2:30 p.m. ET at the Jefferies 2023 Global Healthcare Conference, being held June 7-9, 2023 in New York, NY.
To access the live and subsequent archived webcast, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.
Contact for Investors & Media:
Rigel Pharmaceuticals, Inc.
SOURCE Rigel Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

When will Rigel's CEO present at the Jefferies Conference?

Raul Rodriguez will present on June 7, 2023, at 2:30 p.m. ET.

Where can I find the webcast for Rigel's presentation?

The webcast is available in the Investor Relations section at www.rigel.com.

What does Rigel Pharmaceuticals specialize in?

Rigel focuses on developing therapies for hematologic disorders and cancer.

When was Rigel Pharmaceuticals founded?

Rigel Pharmaceuticals was founded in 1996.

Where is Rigel Pharmaceuticals located?

The company is based in South San Francisco, California.

Tags: RIGL Viatris Investor Conferences Healthcare Rigel Pharmaceuticals hematologic disorders cancer therapies Jefferies Conference Raul Rodriguez
Last updated: May 31, 2023